Integra LifeSciences IART Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableTradeCurrent.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's accounts payable?
- Integra LifeSciences (IART) reported accounts payable of $87.95M in Q1 2026.
- How has Integra LifeSciences's accounts payable changed year-over-year?
- Integra LifeSciences's accounts payable decreased by 3.7% year-over-year, from $91.3M to $87.95M.
- What is the long-term trend for Integra LifeSciences's accounts payable?
- Over 5 years (2020 to 2025), Integra LifeSciences's accounts payable has grown at a 11.9% compound annual growth rate (CAGR), from $54.61M to $95.73M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.